Answer
Azacitidine (Vidaza) should not be used during pregnancy, especially the first trimester, unless clearly necessary, with treatment benefits weighed against possible foetal risks in each case because human data are inadequate and animal studies show reproductive toxicity.
Sources for this answer
- Vidaza 25 mg/ml powder for suspension for injectionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 25Document updated
Sources checked